ADCON-L ANTI-ADHESION CONTROL IN A BARRIER GEL

Inhibitor, Peridural Fibrosis (adhesion Barrier)

FDA Premarket Approval P960057

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for adcon(r)-l adhesion barrier gel. This device is indicated for use during single level, posterior lumbar laminectomy or laminotomy procedures where nerve roots are exposed to inhibit postsurgical peridural fibrosis.

DeviceADCON-L ANTI-ADHESION CONTROL IN A BARRIER GEL
Classification NameInhibitor, Peridural Fibrosis (adhesion Barrier)
Generic NameInhibitor, Peridural Fibrosis (adhesion Barrier)
ApplicantWRIGHTMEDICALTECHNOLOGYINC
Date Received1996-12-23
Decision Date1998-05-27
Notice Date1998-06-23
PMAP960057
SupplementS
Product CodeMLQ
Docket Number98M-0404
Advisory CommitteeNeurology
Expedited ReviewYes
Combination Product No
Applicant Address WRIGHTMEDICALTECHNOLOGYINC 5677 Airline Rd. arlinton, TN 38002

Supplemental Filings

Supplement NumberDateSupplement Type
P960057Original Filing
S011 2000-06-26 Special (immediate Track)
S010
S009
S008 1999-05-13 Special (immediate Track)
S007
S006 1999-03-12 Real-time Process
S005 1999-02-19 135 Review Track For 30-day Notice
S004 1999-02-11 Normal 180 Day Track
S003 1998-12-21 30-day Notice
S002 1998-11-03 Real-time Process
S001 1998-08-28 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.